To verify the differences between early SP RA and SN RA patients, we repeated the measurement of a selected (see “Statistical analysis” for the selection criteria) set of serum markers (IL-1β, IL-15, Eotaxin, Rantes) in independent SP RA and SN RA cohorts (Table 2). The gene discussed is CCL11; the disease is rheumatoid arthritis.